Project Context and Scope

Catenion was engaged by the global head of marketing of a major player in the oncology market to support the systematic definition and implementation of a launch strategy for a key Phase III asset.

Approach:
2 Partners, 2 Consultants for 5 Months

Key Focus on:

• R&D activities
• Regulatory affairs
• Medical affairs
• Marketing plans
• Communication plans and congress planning
• Systematic KOL management process
• Pricing & reimbursement strategy
• Patient access programmes
• Manufacturing & supply chain management
• Integration of regional marketing & sales organisations
• Co–development and co–promotion alignment

Using Catenion's "Market Readiness Assessment," the project covered both North American and European markets.

Key Benefits to the Client

• Catenion brought all of the key parts of the organisation together and delivered and in–depth, two–year plan to the client covering all elements of the launch preparation process.
• Organisational responsibilities, capabilities and budgets were established to support the launch at headquarters and in the marketing and sales subsidiaries.